Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a “game changer” and its first leap in treatment in 50 years, researchers say. According ...

At the time of the attack, the treatment consists of an injection of benralizumab, in a high dose. As reported by the media ...

Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if used to treat acute asthma attacks, calling it the first major advance for this aspect of the disease in 50 ...